object
sever
acut
respiratori
syndrom
sar
caus
new
coronaviru
genom
sequenc
analysi
provid
molecular
epidemiolog
help
develop
vaccin
method
develop
rapid
method
amplifi
sequenc
whole
sarscov
genom
clinic
specimen
techniqu
employ
onestep
multiplex
rtpcr
amplifi
whole
sarscov
genom
nest
pcr
perform
amplifi
region
separ
pcr
product
sequenc
result
sequenc
genom
sarscov
clinic
specimen
obtain
taiwan
sequenc
similar
report
group
except
singl
nucleotid
variat
two
delet
delet
found
variat
clinic
specimen
alter
amino
acid
sequenc
sequenc
variant
two
loci
posit
segreg
togeth
specif
genotyp
c
c
phylogenet
analysi
show
two
major
cluster
sar
patient
taiwan
conclus
develop
econom
rapid
method
sequenc
whole
genom
sarscov
avoid
cultur
influenc
result
sar
patient
taiwan
may
infect
two
differ
origin
atyp
pneumonia
high
contagi
first
appear
guangdong
provinc
peopl
republ
china
novemb
infect
case
caus
death
diseas
spread
hong
kong
first
caus
outbreak
mani
countri
includ
vietnam
canada
singapor
taiwan
countri
almost
individu
infect
die
diseas
sinc
februari
new
deadli
syndrom
first
brought
attent
world
health
organ
dr
carlo
urbani
name
sever
acut
respiratori
syndrom
sar
pathogenesi
sar
believ
novel
coronaviru
sarscov
first
found
peiri
et
al
hong
kong
confirm
group
analysi
genom
sequenc
show
viru
differ
previous
known
coronavirus
serolog
studi
also
confirm
viru
found
human
coronavirida
famili
divers
group
larg
envelop
positivestrand
rna
virus
virus
may
caus
respiratori
enter
infect
human
anim
previous
known
human
coronavirus
frequent
caus
common
cold
lifethreaten
pneumonia
caus
coronavirus
uncommon
gener
speak
genom
coronaviru
largest
kb
length
found
rna
virus
encod
put
protein
includ
major
structur
protein
nucleocapsid
n
spike
membran
envelop
e
protein
n
matur
protein
contribut
gener
host
immun
respons
similarli
genom
sarscov
polyadenyl
rna
gc
content
genom
organ
sarscov
similar
typic
coronaviru
contain
characterist
gene
order
replicas
spike
envelop
membran
short
untransl
region
termini
rna
virus
high
rate
genet
mutat
result
evolut
new
viral
strain
escap
host
defens
import
understand
mutat
rate
sar
viru
spread
popul
develop
effect
vaccin
meanwhil
sever
studi
shown
adapt
viru
nonnatur
host
cell
induc
genet
chang
viral
genom
culturemedi
mutat
may
produc
bia
affect
evolutionari
studi
order
avoid
causat
sequenc
entir
sarscov
directli
use
clinic
specimen
use
approach
abl
analyz
origin
sarscov
infect
accur
collect
clinic
specimen
includ
nasal
pharyng
swab
blood
stool
sar
patient
patient
fit
definit
probabl
sar
case
fever
higher
respiratori
symptom
hypoxia
chest
radiograph
chang
suggest
pneumonia
histori
close
contact
sar
patient
clinic
featur
case
shown
tabl
total
rna
extract
nasopharyng
sampl
patient
use
commerci
kit
qiaamp
viral
rna
mini
kit
qiagen
inc
calif
usa
rtpcr
analysi
sarscov
upstream
primer
downstream
primer
use
amplifi
part
polymeras
gene
method
use
ident
ksiazek
et
al
order
enough
pcr
product
sarscov
genom
sequenc
util
multiplex
onestep
rtpcr
method
amplifi
entir
genom
follow
nest
pcr
separ
amplifi
region
genom
strategi
shown
figur
pcr
product
purifi
sequenc
whole
sarscov
genom
amplifi
two
reaction
primer
use
shown
tabl
use
multiplex
onestep
rtpcr
method
reaction
amplifi
region
genom
nucleo
fig
strategi
sequenc
analysi
sarscov
clinic
specimen
use
two
separ
multiplex
rtpcr
one
contain
pair
primer
contain
pair
primer
amplifi
whole
sarscov
genom
pcr
product
use
templat
nest
pcr
amplifi
region
respect
ensur
whole
sarscov
sequenc
nest
pcr
product
sequenc
analyz
amplifi
differ
reaction
use
primer
pair
respect
primer
shown
tabl
multiplex
onestep
rtpcr
perform
use
commerci
kit
procedur
use
recommend
manufactur
qiagen
onestep
rtpcr
kit
qiagen
inc
briefli
reaction
solut
contain
rna
solut
clinic
extract
primer
buffer
mm
dntp
enzym
mix
unit
rnase
inhibitor
sampl
mixtur
place
thermal
cycler
temperatur
min
incub
min
pcr
amplif
pcr
amplif
consist
step
includ
denatur
anneal
min
extens
min
step
repeat
cycl
nest
pcr
perform
follow
reaction
solut
contain
multiplex
pcr
product
nest
pcr
primer
mm
dntp
taq
buffer
unit
taq
polymeras
pcr
condit
includ
denatur
min
anneal
min
extens
min
step
repeat
cycl
pcr
product
resolv
agaros
gel
proper
pcr
fragment
excis
gel
purifi
use
commerci
kit
qiaex
ii
gel
extract
kit
qiagen
inc
dna
sequenc
perform
use
dideoxi
chain
termin
method
describ
big
dye
tm
termin
cycl
sequenc
use
abi
machin
appli
biosystem
inc
calif
usa
primer
use
sequenc
provid
request
phylogenet
analysi
sarscov
genom
carri
clustalw
http
wwwebiacukclustalwindexhtml
figur
pcr
product
sarscov
fragment
bp
use
specif
primer
fig
among
case
sar
suspect
examin
posit
sarscov
case
use
sequenc
analysi
entir
genom
shihpeckchanchuchentsaichang
clinic
specimen
twc
cultur
specimen
first
case
taiwan
area
midtaiwan
area
twi
tw
twk
twj
twh
northern
part
taiwan
clinic
specimen
whole
sarscov
genom
amplifi
multiplex
rtpcr
two
separ
reaction
follow
differ
nest
pcr
amplifi
fragment
reaction
cover
whole
sarscov
genom
fig
nest
pcr
product
subject
direct
sequenc
result
submit
genbank
access
number
genom
sequenc
clinic
specimen
similar
report
group
compar
genom
found
differ
singl
nucleotid
variat
two
delet
delet
tabl
compar
complet
genom
sequenc
four
clinic
specimen
complet
genom
sequenc
three
cultur
isol
taiwan
differ
shown
tabl
total
singl
nucleotid
sequenc
variat
one
delet
two
nucleotid
noncod
region
base
substitut
alter
origin
amino
acid
code
chang
amino
acid
sequenc
two
missens
mutat
locat
protein
code
area
cy
phe
nt
ala
val
nt
appear
cultur
isol
addit
twobas
delet
mutat
found
cultur
isol
variant
sampl
two
loci
posit
identifi
segreg
togeth
specif
genotyp
c
c
tabl
c
c
genotyp
link
infect
origin
amoy
g
c
c
c
g
c
g
c
g
c
c
twi
c
g
w
c
g
twk
c
g
twj
c
g
w
c
c
c
c
c
g
c
c
w
c
c
c
twh
c
g
c
c
other
c
phylogenet
analysi
shown
figur
analyz
case
associ
hotel
hong
kong
case
taiwan
two
major
cluster
observ
case
analyz
develop
rapid
method
sequenc
analyz
whole
genom
sarscov
clinic
specimen
report
pathogen
microb
undergo
adapt
respons
laboratori
cultur
hostmedi
mutat
sever
virus
document
hiv
japanes
enceph
hepat
sendai
influenza
virus
molecular
evolut
studi
use
sequenc
may
risk
data
contain
laboratori
factor
analyt
data
repres
random
sampl
natur
pathogen
popul
sampl
design
unknown
studi
directli
detect
whole
genom
sarscov
clinic
sampl
avoid
bia
mention
although
clinic
specimen
twc
isol
patient
phylogenet
analysi
reveal
locat
differ
posit
phylogenet
tree
result
confirm
sequenc
cultur
isol
may
differ
clinic
specimen
although
deriv
origin
analyz
sequenc
variant
observ
cultur
isol
clinic
specimen
publish
genbank
interestingli
found
nt
c
g
appear
clinic
specimen
two
cultur
isol
nt
c
found
cultur
isol
except
none
clinic
specimen
tabl
discrep
mutat
may
like
due
cultur
adapt
unabl
complet
exclud
possibl
shift
two
origin
differ
virus
cultur
process
clinic
specimen
cultur
isol
two
variant
segreg
tightli
nt
c
c
c
c
c
c
type
appear
isol
infect
area
world
type
appear
taiwan
area
result
sar
infect
taiwan
could
two
origin
one
either
amoy
garden
hotel
hong
kong
yet
identifi
sequenc
variat
nt
clinic
specimen
variat
chang
amino
acid
code
indic
sarscov
maintain
stabl
structur
may
favor
develop
sarscov
vaccin
cultur
isol
found
missens
mutat
locat
protein
code
region
mutat
may
necessari
cultur
adapt
may
also
appear
clinic
specimen
caus
factor
immunolog
adapt
protein
sarscov
may
play
import
role
immun
respons
infect
patient
multiplex
rtpcr
method
use
studi
express
ten
gene
simultan
detect
pathogen
subtyp
verifi
multipl
chromosom
transloc
order
increas
specif
nest
pcr
probe
enzym
hybrid
method
microarray
use
studi
use
multiplex
rtpcr
amplifi
whole
sar
genom
two
separ
reaction
pcr
product
amplifi
use
pair
nest
primer
product
cover
whole
genom
separ
tube
pcr
product
sequenc
similar
approach
use
analyz
hn
gene
human
parainfluenza
viru
howev
small
portion
human
parainfluenza
genom
analyz
contrast
report
analyz
whole
genom
biggest
rna
viru
although
multipl
rtpcr
amplifi
whole
sar
genom
use
detect
method
difficult
evalu
quantit
chang
clinic
specimen
first
amplifi
pol
region
sar
viru
detect
viru
evalu
quantit
chang
sar
viru
use
multiplex
rtpcr
direct
sequenc
analyz
whole
genom
